HIMS
Hims & Hers Health, Inc.
$30.83
▲ +11.00%
+$3.06
Hims & Hers Health, Inc.
today's anomalyHIMS · NYSE · Healthcare · Drug Manufacturers - Specialty & Generic · price updated 9h ago
$30.83
▲ +11.00% · +$3.06 today
AI research · $30.83
HIMS, researched
HIMS coverage is quiet
refreshed Aug 3
price position
Where HIMS sits now
52-week range
Low$13.74
High$70.43
Today $30.83
RSI (14)
41.9Neutral
03070100
today's move
▲ +11.0%+$3.06
HIMS reverses losses and clears its recent closing range
medHIMS rose 11.0%, opposing the prior-window return of -8.17% and moving above the supplied recent closing-price high of 30.24. It outperformed the market by 9.48 percentage points, while volume was 25.07% below its recent average; no verified news catalyst surfaced.
fundamentals
Business quality and valuation
Operating record
What the business has actually produced
Revenue
Capital structure
Cash versus debt
Cash & investments$750.9M
Total debt$1.1B
Net cash after debt$-381.2M
Valuation
What the market charges
Forward P/E
Price against expected earnings
Needs attention · 308% above Sector avg
32.51x
Price / sales
Value assigned to each sales dollar
Strong · Under 3x annual sales
2.71x
Price / FCF
Price against free cash generation
Rich · Above 35x free cash flow
80.64x
EV / EBITDA
Operating value including debt
Rich · Above 22x EBITDA
181.22x
Quality
How efficiently it compounds
ROIC
Return earned on invested capital
Weak · Below 8% return on capital
1.6%
ROE
Profit generated from shareholder equity
Needs attention · Among weakest in sector
-2.7%
Debt / equity
Balance-sheet leverage
Needs attention · Among weakest in sector
2.54x
Current ratio
Short-term assets against liabilities
Strong · Comfortable short-term liquidity
1.69x
Selected financial data sourced from StockAnalysis and refreshed weekly. Figures may be delayed and are for research context, not investment advice.
peer comparison
How HIMS compares
| company | mkt cap | P/E | rev growth | score |
|---|---|---|---|---|
| $6.43B | - | +32.8% | 37 |
 | $10.69B | 18.4 | +23.5% | 78 |
 | $4.88B | 20.3 | +10.3% | 77 |
 | $31.49B | 32.9 | +15.5% | 77 |
 | $1.08T | 41.4 | +47.4% | 76 |
US stock research
About Hims & Hers Health, Inc. (HIMS) stock
Hims & Hers Health, Inc. trades on NYSE under the ticker HIMS. HIMS was +11.0% in the latest available session at $30.83. Its reported market value was $6.43B with a trailing P/E of 0.0. Latest reported revenue was $2.37B, changing +32.8% year over year, with $-13.24M in net income.
Market snapshot updated Aug 3, 2026, 7:59 PM UTC.
- Latest available price
- $30.83
- Day change
- +11.0%
- Market cap
- $6.43B
- P/E (TTM)
- 0.0
- Revenue growth
- +32.8%
- Industry
- Drug Manufacturers - Specialty & Generic